Published in Breast Cancer Res Treat on May 31, 2007
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. J Natl Cancer Inst (2012) 5.27
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ (2010) 4.73
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study. J Clin Oncol (2011) 2.47
Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes. Clin Pharmacol Ther (2011) 2.09
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol (2008) 1.64
Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2011) 1.57
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients. Pharmacogenomics J (2009) 1.43
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort. Breast Cancer Res Treat (2009) 1.20
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids (2007) 1.17
In vitro cytochrome P450-mediated metabolism of exemestane. Drug Metab Dispos (2010) 1.10
Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer. BMC Cancer (2010) 1.06
Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat (2011) 0.98
Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study. Am J Clin Nutr (2009) 0.98
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia (2010) 0.97
Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trials. Curr Opin Obstet Gynecol (2009) 0.97
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Res Treat (2012) 0.95
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer. Br J Cancer (2010) 0.94
Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer. Breast Care (Basel) (2008) 0.92
Cognitive changes associated with endocrine therapy for breast cancer. Maturitas (2010) 0.87
Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol (2012) 0.87
Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast Cancer Res Treat (2013) 0.86
The Discriminatory Value of CYP2D6 Genotyping in Predicting the Dextromethorphan/Dextrorphan Phenotype in Women with Breast Cancer. Breast Care (Basel) (2012) 0.85
Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw (2010) 0.81
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women. Ther Clin Risk Manag (2009) 0.81
In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4. Xenobiotica (2011) 0.79
Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial. J Clin Oncol (2009) 0.78
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites. BMC Cancer (2013) 0.78
Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer. Front Genet (2013) 0.78
Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial. Br J Cancer (2012) 0.77
Update on the use of aromatase inhibitors in early-stage breast cancer. Breast Cancer Res (2009) 0.77
Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis. PLoS One (2013) 0.76
Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients. Chin J Cancer Res (2011) 0.76
Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients. Mol Clin Oncol (2015) 0.75
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Res (2016) 0.75
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst (2003) 8.66
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol (2005) 6.90
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin Pharmacol Ther (2006) 4.81
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat (2006) 4.35
Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther (2004) 3.84
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials (2002) 3.41
Hot flashes: epidemiology and physiology. Ann N Y Acad Sci (1990) 2.70
Hot flushes. Lancet (2002) 2.28
Women's health initiative. Why now? What is it? What's new? Am Psychol (1997) 2.14
Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer (1998) 1.65
Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol (1995) 1.43
Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology (2004) 1.33
A universal menopausal syndrome? Am J Med (2005) 1.24
Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) (1985) 1.19
Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril (2002) 1.19
Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol (2005) 1.03
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol (2007) 3.88
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A (2004) 3.65
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials (2002) 3.41
Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord (2007) 2.74
Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women's health across the nation. Am J Epidemiol (2006) 2.61
Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women's Health Across the Nation. Menopause (2008) 2.49
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health (2008) 2.46
The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun (2006) 2.40
Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep (2008) 2.37
Clean indoor air: advances in California, 1990-1999. Am J Public Health (2002) 2.35
Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer. Am J Health Behav (2007) 2.34
Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas (2010) 2.30
Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res (2003) 2.24
The effect of smoke-free homes on adult smoking behavior: a review. Nicotine Tob Res (2009) 2.20
Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol (2006) 2.20
The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab (2005) 2.15
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. Sleep (2009) 2.13
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res (2004) 2.10
Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer (2005) 2.08
The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation. Tob Control (2007) 2.04
Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health (2002) 2.02
Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab (2005) 1.99
Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab (2010) 1.93
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc (2003) 1.91
Do favorite movie stars influence adolescent smoking initiation? Am J Public Health (2004) 1.89
Home smoking bans among U.S. households with children and smokers. Opportunities for intervention. Am J Prev Med (2011) 1.88
Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab (2004) 1.81
Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol (2010) 1.80
Receptivity to tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood. Am J Public Health (2007) 1.79
The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg (2008) 1.78
Increases in plasma carotenoid concentrations in response to a major dietary change in the women's healthy eating and living study. Cancer Epidemiol Biomarkers Prev (2006) 1.78
How do smokers control their cigarette expenditures? Nicotine Tob Res (2005) 1.78
Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr (2004) 1.75
Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry (2010) 1.73
Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation. Menopause (2013) 1.72
APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther (2004) 1.71
Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis (2010) 1.69
Do the majority of Asian-American and African-American smokers start as adults? Am J Prev Med (2004) 1.69
Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc (2008) 1.68
Physical activity and menstrual cycle characteristics in two prospective cohorts. Am J Epidemiol (2002) 1.66
Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat (2006) 1.66
Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am J Epidemiol (2003) 1.65
The effect of smoke-free homes on smoking behavior in the U.S. Am J Prev Med (2008) 1.64
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol (2008) 1.64
Validity and systematic error in measuring carotenoid consumption with dietary self-report instruments. Am J Epidemiol (2006) 1.62
Demographic differences in patterns in the incidence of smoking cessation: United States 1950-1990. Ann Epidemiol (2002) 1.60
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat (2006) 1.59
Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer. Cancer Biol Ther (2004) 1.57
Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause. Menopause (2011) 1.53
Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med (2009) 1.53
Cigarette promotional offers: who takes advantage? Am J Prev Med (2006) 1.52
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
What fraction of young adults are at risk for future smoking, and who are they? Nicotine Tob Res (2005) 1.48
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab (2002) 1.47
Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol (2007) 1.46
Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002. J Womens Health (Larchmt) (2007) 1.46
Mammographic density in a multiethnic cohort. Menopause (2007) 1.45
Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat (2010) 1.42
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol (2005) 1.40
Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study. Cancer Causes Control (2010) 1.39
The California Tobacco Control Program's effect on adult smokers: (2) Daily cigarette consumption levels. Tob Control (2007) 1.39
Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology (2006) 1.38